BABA vs LZB

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

La-Z-Boy exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a conservative debt-to-equity ratio of 0.54. While the current price of $35.21 aligns closely with the Graham Number ($33.86), suggesting defensive fair value, there is a stark divergence from the growth-based intrinsic value of $14.0. The company is currently battling significant earnings contraction (-23.5% YoY) despite modest revenue growth. The outlook is a tug-of-war between a robust balance sheet and deteriorating profitability trends.